University of Glasgow-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

1999

  1. Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion

    Annals of Oncology, Vol. 10, Núm. 3, pp. 339-344

1995

  1. Doxorubicin-induced cardiotoxicity

    New England Journal of Medicine

  2. Prognostic factors in bladder cancer after primary M-VAC [2]

    Journal of Clinical Oncology

1994

  1. The management of non-seminomatous germ cell tumours (GCT)

    Annals of Oncology, Vol. 5, Núm. 5, pp. 457-462